|
1
|
Renga B: Hydrogen sulfide generation in
mammals: the molecular biology of cystathionine-β-synthase (CBS)
and cystathionine-γ-lyase (CSE). Inflamm Allergy Drug Targets.
10:85–91. 2011.
|
|
2
|
Zhang LM, Jiang CX and Liu DW: Hydrogen
sulfide attenuates neuronal injury induced by vascular dementia via
inhibiting apoptosis in rats. Neurochem Res. 34:1984–1992. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ahmad FU, Sattar MA, Rathore HA, et al:
Exogenous hydrogen sulfide (H2S) reduces blood pressure
and prevents the progression of diabetic nephropathy in
spontaneously hypertensive rats. Ren Fail. 34:203–210.
2012.PubMed/NCBI
|
|
4
|
Qipshidze N, Metreveli N, Mishra PK,
Lominadze D and Tyagi SC: Hydrogen sulfide mitigates cardiac
remodeling during myocardial infarction via improvement of
angiogenesis. Int J Biol Sci. 8:430–441. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olson KR, Whitfield NL, Bearden SE, et al:
Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen
sulfide mechanism. Am J Physiol Regul Integr Comp Physiol.
298:R51–R60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chattopadhyay M, Kodela R, Nath N, et al:
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human
cancer cells: a general property and evidence of a tissue
type-independent effect. Biochem Pharmacol. 83:715–722. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chattopadhyay M, Kodela R, Nath N,
Barsegian A, Boring D and Kashfi K: Hydrogen sulfide-releasing
aspirin suppresses NF-κB signaling in estrogen receptor negative
breast cancer cells in vitro and in vivo. Biochem Pharmacol.
83:723–732. 2012.PubMed/NCBI
|
|
8
|
Frantzias J, Logan JG, Mollat P, et al:
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast
cancer-induced osteoclastogenesis in vitro and prevent osteolysis
ex vivo. Br J Pharmacol. 165:1914–1925. 2012. View Article : Google Scholar
|
|
9
|
Daroqui MC, Vazquez P, Bal de Kier Joffé
E, Bakin AV and Puricelli LI: TGF-β autocrine pathway and MAPK
signaling promote cell invasiveness and in vivo mammary
adenocarcinoma tumor progression. Oncol Rep. 28:567–575. 2012.
|
|
10
|
Wendt MK, Smith JA and Schiemann WP:
Transforming growth factor-β-induced epithelial-mesenchymal
transition facilitates epidermal growth factor-dependent breast
cancer progression. Oncogene. 29:6485–6498. 2010.
|
|
11
|
Fang LP, Lin Q, Tang CS and Liu XM:
Hydrogen sulfide attenuates epithelial-mesenchymal transition of
human alveolar epithelial cells. Pharmacol Res. 61:298–305. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang L, Li H, Tang C, Geng B, Qi Y and Liu
X: Hydrogen sulfide attenuates the pathogenesis of pulmonary
fibrosis induced by bleomycin in rats. Can J Physiol Pharmacol.
87:531–538. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan HN, Wang HJ, Ren L, et al: Decreased
expression of p38 MAPK mediates protective effects of hydrogen
sulfide on hepatic fibrosis. Eur Rev Med Pharmacol Sci. 17:644–652.
2013.PubMed/NCBI
|
|
14
|
Fang LP, Lin Q, Tang CS and Liu XM:
Hydrogen sulfide suppresses migration, proliferation and
myofibroblast transdifferentiation of human lung fibroblasts. Pulm
Pharmacol Ther. 22:554–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Y, Liu X, Zheng Q, et al: Hydrogen
sulfide prevents hypoxia-induced apoptosis via inhibition of an
H2O2-activated calcium signaling pathway in
mouse hippocampal neurons. Biochem Biophys Res Commun. 425:473–477.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou X and Lu X: Hydrogen sulfide inhibits
high-glucose-induced apoptosis in neonatal rat cardiomyocytes. Exp
Biol Med (Maywood). 238:370–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bos EM, Snijder PM, Jekel H, et al:
Beneficial effects of gaseous hydrogen sulfide in hepatic
ischemia/reperfusion injury. Transpl Int. 25:897–908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pei Y, Wu B, Cao Q, Wu L and Yang G:
Hydrogen sulfide mediates the anti-survival effect of sulforaphane
on human prostate cancer cells. Toxicol Appl Pharmacol.
257:420–428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sánchez-Tilló E, Liu Y, de Barrios O, et
al: EMT-activating transcription factors in cancer: beyond EMT and
tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012.PubMed/NCBI
|
|
21
|
Ma K, Liu Y, Zhu Q, et al: H2S
donor, S-propargyl-cysteine, increases CSE in SGC-7901 and
cancer-induced mice: evidence for a novel anti-cancer effect of
endogenous H2S? PLoS One. 6:e205252011.
|
|
22
|
del Barco Barrantes I and Nebreda AR:
Roles of p38 MAPKs in invasion and metastasis. Biochem Soc Trans.
40:79–84. 2012.PubMed/NCBI
|
|
23
|
Chen HH, Zhou XL, Shi YL and Yang J: Roles
of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to
mesenchymal transition. Arch Med Res. 44:93–98. 2013.
|
|
24
|
Antoon JW, Nitzchke AM, Martin EC, et al:
Inhibition of p38 mitogen-activated protein kinase alters microRNA
expression and reverses epithelial-to-mesenchymal transition. Int J
Oncol. 42:1139–1150. 2013.PubMed/NCBI
|
|
25
|
Yang Y, Li Y, Wang K, Wang Y, Yin W and Li
L: P38/NF-κB/snail pathway is involved in caffeic acid-induced
inhibition of cancer stem cells-like properties and migratory
capacity in malignant human keratinocyte. PLoS One.
8:e589152013.PubMed/NCBI
|
